214 related articles for article (PubMed ID: 15864120)
21. Discovery of a novel allelic variant of CYP2C8, CYP2C8*11, in Asian populations and its clinical effect on the rosiglitazone disposition in vivo.
Yeo CW; Lee SJ; Lee SS; Bae SK; Kim EY; Shon JH; Rhee BD; Shin JG
Drug Metab Dispos; 2011 Apr; 39(4):711-6. PubMed ID: 21245287
[TBL] [Abstract][Full Text] [Related]
22. CYP2J2*7 single nucleotide polymorphism in a Chinese population.
Wang H; Jiang Y; Liu Y; Lin C; Cheng G; Chen X; Hao B; Tan W; Lin D; He F
Clin Chim Acta; 2006 Mar; 365(1-2):125-8. PubMed ID: 16182271
[TBL] [Abstract][Full Text] [Related]
23. Promoter polymorphism G-50T of a human CYP2J2 epoxygenase gene is associated with common susceptibility to asthma.
Polonikov AV; Ivanov VP; Solodilova MA; Khoroshaya IV; Kozhuhov MA; Panfilov VI
Chest; 2007 Jul; 132(1):120-6. PubMed ID: 17475630
[TBL] [Abstract][Full Text] [Related]
24. A comprehensive study revealed SNP-SNP interactions and a sex-dependent relationship between polymorphisms of the CYP2J2 gene and hypertension risk.
Polonikov AV; Ponomarenko IV; Bykanova MA; Sirotina SS; Bocharova AV; Vagaytseva KV; Stepanov VA; Azarova IE; Churnosov MI; Solodilova MA
Hypertens Res; 2019 Feb; 42(2):257-272. PubMed ID: 30518987
[TBL] [Abstract][Full Text] [Related]
25. Polymorphism of CYP2D6, CYP2C19, CYP2C9 and CYP2C8 in the Faroese population.
Halling J; Petersen MS; Damkier P; Nielsen F; Grandjean P; Weihe P; Lundgren S; Lundblad MS; Brøsen K
Eur J Clin Pharmacol; 2005 Aug; 61(7):491-7. PubMed ID: 16025294
[TBL] [Abstract][Full Text] [Related]
26. Characterisation of CYP2C8, CYP2C9 and CYP2C19 polymorphisms in a Ghanaian population.
Kudzi W; Dodoo AN; Mills JJ
BMC Med Genet; 2009 Dec; 10():124. PubMed ID: 19954515
[TBL] [Abstract][Full Text] [Related]
27. Association of genetic polymorphisms of CYP 2C19 with hypertension in a Chinese Han population.
Ma Y; Ni W; Zhu W; Xiong Y; Deng X
Blood Press; 2011 Jun; 20(3):166-70. PubMed ID: 21332417
[TBL] [Abstract][Full Text] [Related]
28. Endothelial expression of human cytochrome P450 epoxygenase CYP2C8 increases susceptibility to ischemia-reperfusion injury in isolated mouse heart.
Edin ML; Wang Z; Bradbury JA; Graves JP; Lih FB; DeGraff LM; Foley JF; Torphy R; Ronnekleiv OK; Tomer KB; Lee CR; Zeldin DC
FASEB J; 2011 Oct; 25(10):3436-47. PubMed ID: 21697548
[TBL] [Abstract][Full Text] [Related]
29. Sex- and isoform-specific mechanism of neuroprotection by transgenic expression of P450 epoxygenase in vascular endothelium.
Jia J; Davis CM; Zhang W; Edin ML; Jouihan S; Jia T; Bradbury JA; Graves JP; DeGraff LM; Lee CR; Ronnekleiv O; Wang R; Xu Y; Zeldin DC; Alkayed NJ
Exp Neurol; 2016 May; 279():75-85. PubMed ID: 26902473
[TBL] [Abstract][Full Text] [Related]
30. Genetic markers in the EET metabolic pathway are associated with outcomes in patients with aneurysmal subarachnoid hemorrhage.
Donnelly MK; Conley YP; Crago EA; Ren D; Sherwood PR; Balzer JR; Poloyac SM
J Cereb Blood Flow Metab; 2015 Feb; 35(2):267-76. PubMed ID: 25388680
[TBL] [Abstract][Full Text] [Related]
31. Genetic polymorphisms of CYP2C8 in the Czech Republic.
Pechandova K; Buzkova H; Matouskova O; Perlik F; Slanar O
Genet Test Mol Biomarkers; 2012 Jul; 16(7):812-6. PubMed ID: 22313047
[TBL] [Abstract][Full Text] [Related]
32. The effect of the cytochrome P450 CYP2C8 polymorphism on the disposition of (R)-ibuprofen enantiomer in healthy subjects.
Martínez C; García-Martín E; Blanco G; Gamito FJ; Ladero JM; Agúndez JA
Br J Clin Pharmacol; 2005 Jan; 59(1):62-9. PubMed ID: 15606441
[TBL] [Abstract][Full Text] [Related]
33. Relationship between CYP2C8 genotypes and diclofenac 5-hydroxylation in healthy Spanish volunteers.
Dorado P; Cavaco I; Cáceres MC; Piedade R; Ribeiro V; Llerena A
Eur J Clin Pharmacol; 2008 Oct; 64(10):967-70. PubMed ID: 18548238
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics and pharmacodynamics of rosiglitazone in relation to CYP2C8 genotype.
Kirchheiner J; Thomas S; Bauer S; Tomalik-Scharte D; Hering U; Doroshyenko O; Jetter A; Stehle S; Tsahuridu M; Meineke I; Brockmöller J; Fuhr U
Clin Pharmacol Ther; 2006 Dec; 80(6):657-67. PubMed ID: 17178266
[TBL] [Abstract][Full Text] [Related]
35. Polymorphic organic anion transporting polypeptide 1B1 is a major determinant of repaglinide pharmacokinetics.
Niemi M; Backman JT; Kajosaari LI; Leathart JB; Neuvonen M; Daly AK; Eichelbaum M; Kivistö KT; Neuvonen PJ
Clin Pharmacol Ther; 2005 Jun; 77(6):468-78. PubMed ID: 15961978
[TBL] [Abstract][Full Text] [Related]
36. Interindividual variability in ibuprofen pharmacokinetics is related to interaction of cytochrome P450 2C8 and 2C9 amino acid polymorphisms.
García-Martín E; Martínez C; Tabarés B; Frías J; Agúndez JA
Clin Pharmacol Ther; 2004 Aug; 76(2):119-27. PubMed ID: 15289789
[TBL] [Abstract][Full Text] [Related]
37. Genetic variation in the cytochrome P450 epoxygenase pathway and cardiovascular disease risk.
Theken KN; Lee CR
Pharmacogenomics; 2007 Oct; 8(10):1369-83. PubMed ID: 17979511
[TBL] [Abstract][Full Text] [Related]
38. CYP2C8 polymorphisms in Caucasians and their relationship with paclitaxel 6alpha-hydroxylase activity in human liver microsomes.
Bahadur N; Leathart JB; Mutch E; Steimel-Crespi D; Dunn SA; Gilissen R; Houdt JV; Hendrickx J; Mannens G; Bohets H; Williams FM; Armstrong M; Crespi CL; Daly AK
Biochem Pharmacol; 2002 Dec; 64(11):1579-89. PubMed ID: 12429347
[TBL] [Abstract][Full Text] [Related]
39. Mutational analysis of CYP2C8 in hypertensive patients using denaturing high performance liquid chromatography.
Teh LK; Zahri MK; Zakaria ZA; Ismail R; Salleh MZ
J Clin Pharm Ther; 2010 Dec; 35(6):723-8. PubMed ID: 21054465
[TBL] [Abstract][Full Text] [Related]
40. Cloning of CYP2J2 gene and identification of functional polymorphisms.
King LM; Ma J; Srettabunjong S; Graves J; Bradbury JA; Li L; Spiecker M; Liao JK; Mohrenweiser H; Zeldin DC
Mol Pharmacol; 2002 Apr; 61(4):840-52. PubMed ID: 11901223
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
